ACell

From Wikipedia, the free encyclopedia
Jump to: navigation, search

ACell, Incorporated is a Columbia, Maryland-based biotechnology company. The company works in regenerative medicine, in which it owns several extracellular matrix patents.[1] ACell develops, manufactures and markets products for medical and veterinary applications.[2] The company is founded by Alan R. Spievack, a former associate professor at Harvard Medical School and currently run by Patrick A. McBrayer.[3][4]

ACell's use of porcine cellular structure, called MatriStem, as a scaffold for human tissue regeneration was named the "medical breakthrough of the year" by Esquire.[5] The use of pig bladder ground up into "magical pixie dust" to regrow Spievak's brother's finger received considerable mainstream coverage.[6][7] Ken Muneoka of Tulane University, who works with ACell's scientific advisors on US-government funded investigations into regenerative medicine, said that the news should be viewed with caution because it was not a controlled study.[5]

References[edit]

  1. ^ "ACell wins extracellular matrix patent battle initiated by Cook Biotech and Purdue.". BIOTECH Patent News (August, 2006). 2006-08-01. Retrieved 2008-05-01. 
  2. ^ "Acell Inc. completes $6M round of financing". The Daily Record. 2004-03-23. Retrieved 2008-05-01. 
  3. ^ http://www.prnewswire.com/news-releases/acell-inc-names-patrick-mcbrayer-chief-executive-officer-300201836.html
  4. ^ "Reborn, ACell enters medical wound healing". Maryland Gazette. Retrieved 2008-05-01. 
  5. ^ a b "No. 3: Medical Breakthrough of the Year". Esquire. Archived from the original on 8 May 2008. Retrieved 2008-05-01. 
  6. ^ "Man regrew finger - with pig powder?". New York Daily News. 2008-04-30. Archived from the original on 3 May 2008. Retrieved 2008-05-01. 
  7. ^ Price, Matthew (2008-04-30). "The man who grew a finger". BBC. Archived from the original on 5 May 2008. Retrieved 2008-05-01.